Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAfter a weekly semaglutide injection, the medicine reaches its peak concentration in your bloodstream roughly 24 to 72 hours later — most commonly around one to three days after the dose. That window is consistent across the dose schedule, from the starting 0.25 mg right through to the 2.4 mg or 7.2 mg maintenance levels. It is worth knowing upfront, though, that peak plasma concentration tells you when the drug is at its highest level, not necessarily when you will feel the most pronounced effects on appetite or nausea — those experiences vary considerably from person to person. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a prescriber assesses your suitability before it is supplied.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide is absorbed slowly from the subcutaneous injection site. In clinical pharmacology studies, the time to maximum plasma concentration (Tmax) falls within a 24–72 hour window after the injection, with a central estimate of around 24–48 hours for most people. So if you inject on a Monday morning, peak levels are typically somewhere between Monday evening and Wednesday.
That gradual absorption is by design. Semaglutide is formulated to act slowly, which is part of why its effects on appetite and blood-sugar regulation are sustained across the whole week rather than concentrated in the hours immediately following the jab. The NHS medicine information for semaglutide gives a clear overview of how the medicine works and what to expect each week.
One thing that often surprises people: knowing the Tmax figure does not tell you when you will feel the most nauseous or the least hungry. Those symptoms are influenced by the dose level, your individual tolerance, what you eat, and how far along you are in the titration schedule, not simply by the clock ticking past 48 hours. If you want to understand when semaglutide is truly at its peak and what that means in practice, that distinction is worth exploring before drawing conclusions from the pharmacokinetic number alone. Our page on semaglutide's peak effects looks at this distinction in more detail.
The Tmax window (that 24–72 hour range) stays broadly consistent regardless of which dose you are on. What changes as titration progresses is the absolute concentration at peak: a 2.4 mg dose produces a higher peak plasma level than a 0.25 mg dose, as you would expect.
This is why the dose-escalation schedule exists. Starting at 0.25 mg for the first four weeks lets your gut adapt to lower concentrations before the prescriber moves you up. At each step the peak is higher, which is one reason GI side effects like nausea or an unsettled stomach tend to surface again briefly after a dose increase (the body is meeting a new peak it has not encountered before) then typically settle within a couple of weeks as tolerance builds.
If you are curious about when semaglutide peaks at higher doses, the short answer is that the timing stays similar but the magnitude grows. That is why clinical monitoring and prescriber support matter more at each step up, not less.
Semaglutide has a half-life of approximately one week, closely matched to the dosing interval. That is significant because it means the drug does not fully clear your system between injections. With each successive weekly dose, a proportion of the previous week's medicine is still present when the new dose arrives. The result is accumulation.
Steady state, the point at which weekly peak and trough levels stabilise rather than climbing further, is reached after roughly four to five weeks on a consistent dose. By that point the fluctuation between the peak (a day or two after injection) and the trough (just before the next one) narrows relative to the earlier weeks. Many people find that some of the initial side effects ease around this time, partly because those fluctuations are smoothing out.
Understanding steady state also matters practically: if you miss a dose, the trough drops lower than it otherwise would, which can affect both tolerability and efficacy when you resume. The NHS guidance on what to do if you miss a semaglutide dose and the Patient Information Leaflet are the right places to turn, not a general estimate of peak timing.
For a broader look at how long semaglutide takes to work on appetite and weight, the timeline extends well beyond steady state pharmacokinetics into weeks and months of consistent treatment.
Because semaglutide is injected once weekly rather than daily, the time of day matters less than the day of the week. The 24–72 hour absorption window is the same whether you inject at 8am or 8pm. That said, some people find a consistent time of day helpful for routine, and there are practical reasons to think about it. If nausea tends to be most noticeable in the first day or two after injection, an evening dose means any unsettled feeling peaks overnight when you may be less aware of it.
There is no clinical requirement to inject at a specific time of day; what counts is keeping the same day each week. For a fuller discussion of the best time of day to take semaglutide, including practical tips from people who have found a routine that works, that page covers the specifics.
If you are considering Wegovy and want to understand what private treatment costs in the UK, that information is on our pricing page. The right starting point for most people, though, is understanding whether semaglutide is clinically appropriate for them. It is an honest question our prescribers hear regularly, and if you are weighing this up, speaking to our clinical team is straightforward and free to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.